Trade Mark Journal No.2026/046 13 November 2026

UK00004468952 2 November 2026 (5)

OTIGO EAREASE

Class 5: Pharmaceutical and related medicinal preparations for the treatment of and relief of pain from acute, congestive otitis media of the middle ear without tympanic perforation; Pharmaceutical and related medicinal preparations for the treatment of and relief of pain from otitis in influenza (bullous otitis) of the middle ear without tympanic perforation; Pharmaceutical and related medicinal preparations for the treatment of and relief of pain from barotraumatic otiti of the middle ear without tympanic perforation; Pharmaceutical and related medicinal preparations for the treatment of ear diseases and disorders; Pharmaceutical and related medicinal preparations for the treatment of and relief of pain from ear diseases and disorders.

Renascience Pharma Limited

Representative: J A Kemp LLP